You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Osteoporosis

Osteoporosis: assessing the risk of fragility fracture

  • Clinical guideline
  • Reference number: CG146
  • Published:  08 August 2012
  • Last updated:  07 February 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download (PDF)
  • About this information
  • Your care
  • Osteoporosis-related fractures
  • Who should be assessed for fracture risk?
  • How should fracture risk be assessed?
  • More information
  • Other NICE guidance

Other NICE guidance

NICE has also produced the following guidance:

  • Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women

  • Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women

  • Falls in older people: assessing risk and prevention

  • Hip fracture: management

ISBN: 978-1-4731-3517-8

This page was last updated: 01 August 2012


Previous page More information
Back to top